Figs Inc
NYSE:FIGS

Watchlist Manager
Figs Inc Logo
Figs Inc
NYSE:FIGS
Watchlist
Price: 5.05 USD 3.27% Market Closed
Market Cap: 820.7m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one FIGS stock under the Base Case scenario is 7.51 USD. Compared to the current market price of 5.05 USD, Figs Inc is Undervalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FIGS Relative Value
Base Case
7.51 USD
Undervaluation 33%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.5
P/S
P/S
Price to Sales
1.5
vs History
90
vs Industry
57
Median 3Y
2
Median 5Y
2.3
Industry
2.2
Forward
1.5
More Details
301.3
P/E
P/E
Price to Earnings
301.3
vs History
9
vs Industry
1
Median 3Y
57.3
Median 5Y
56.2
Industry
21.9
Forward
87.2
More Details
10.1
P/OCF
P/OCF
Price to OCF
10.1
vs History
52
vs Industry
37
Median 3Y
10.3
Median 5Y
10.4
Industry
13.5
More Details
12.8
P/FCFE
P/FCFE
Price to FCFE
12.8
vs History
50
vs Industry
30
Median 3Y
12.3
Median 5Y
12.8
Industry
19.3
More Details
2.2
P/B
P/B
Price to Book Value
2.2
vs History
88
vs Industry
41
Median 3Y
3.1
Median 5Y
3.6
Industry
2.1
More Details
1
EV/S
EV/S
Enterprise Value to Sales
1
vs History
90
vs Industry
68
Median 3Y
1.6
Median 5Y
1.9
Industry
2.3
Forward
1
More Details
1.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.5
vs History
88
vs Industry
76
Median 3Y
2.3
Median 5Y
2.7
Industry
4.8
More Details
64.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
64.1
vs History
31
vs Industry
4
Median 3Y
32.1
Median 5Y
39
Industry
11.5
Forward
10.7
More Details
253.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
253.6
vs History
24
vs Industry
1
Median 3Y
34.7
Median 5Y
43.2
Industry
15.6
Forward
40.5
More Details
7.1
EV/OCF
EV/OCF
Enterprise Value to OCF
7.1
vs History
54
vs Industry
46
Median 3Y
7.7
Median 5Y
7.7
Industry
13.3
More Details
9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
9
vs History
50
vs Industry
36
Median 3Y
8.9
Median 5Y
9.5
Industry
17.3
More Details
2.3
EV/IC
EV/IC
Enterprise Value to IC
2.3
vs History
90
vs Industry
36
Median 3Y
3.9
Median 5Y
4.6
Industry
1.8
More Details

Multiples Across Competitors

FIGS Competitors Multiples
Figs Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Figs Inc
NYSE:FIGS
819.5m USD 1.5 301.3 64.1 253.6
CH
Alcon AG
SIX:ALC
39.4B CHF 4.8 46.5 19.5 37.3
JP
Hoya Corp
TSE:7741
6.1T JPY 7 30.2 18.8 22.4
DK
Coloplast A/S
CSE:COLO B
145.4B DKK 5.3 29.8 18.6 22
US
Align Technology Inc
NASDAQ:ALGN
13.4B USD 3.3 31.7 15.1 18.3
UK
ConvaTec Group PLC
LSE:CTEC
5.3B GBP 3 36.5 208.5 341
CH
Ypsomed Holding AG
SIX:YPSN
4.8B CHF 7.7 64.2 31 58.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
41.1B CNY 11.7 29.5 25.3 25.3
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.7B USD 4.1 46.4 21.4 37.4
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.5B USD 3.6 17.6 10.1 11.5
KR
HLB Inc
KOSDAQ:028300
7.5T KRW 109.7 -81.3 -66 -62.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Figs Inc
NYSE:FIGS
Average EV/EBITDA: 43.2
64.1
99%
0.6
CH
Alcon AG
SIX:ALC
19.5
11%
1.8
JP
Hoya Corp
TSE:7741
18.8
N/A N/A
DK
Coloplast A/S
CSE:COLO B
18.6
11%
1.7
US
Align Technology Inc
NASDAQ:ALGN
15.1
16%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
208.5
10%
20.8
CH
Ypsomed Holding AG
SIX:YPSN
31
31%
1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.3
26%
1
US
Merit Medical Systems Inc
NASDAQ:MMSI
21.4
14%
1.5
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.1
23%
0.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -66 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Figs Inc
NYSE:FIGS
Average EV/EBIT: 82.7
253.6
112%
2.3
CH
Alcon AG
SIX:ALC
37.3
25%
1.5
JP
Hoya Corp
TSE:7741
22.4
N/A N/A
DK
Coloplast A/S
CSE:COLO B
22
12%
1.8
US
Align Technology Inc
NASDAQ:ALGN
18.3
17%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
341
22%
15.5
CH
Ypsomed Holding AG
SIX:YPSN
58.2
45%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.3
16%
1.6
US
Merit Medical Systems Inc
NASDAQ:MMSI
37.4
28%
1.3
US
Lantheus Holdings Inc
NASDAQ:LNTH
11.5
26%
0.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -62.5 N/A N/A

See Also

Summary
FIGS intrinsic value, competitors valuation, and company profile.
DCF Valuation
FIGS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FIGS stock valuation using valuation multiples.
Wall Street Estimates
FIGS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FIGS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 253,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.